Phase II trial of abraxane administered on a weekly schedule in combination with bevacizumab in metastatic breast cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Oct 2007
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 19 Oct 2007 Status changed from recruiting to in progress.
- 03 Mar 2007 New trial record.